About Incyte Biosciences Iberia

More than 20 years at the service of pharmaceutical innovation.

Incyte is a global biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapies. Our hallmark scientific innovation is based on our unique competencies in medicinal chemistry and biology, which drives us to discover and develop the best first-in-class medicines.

World-class science and R&D are Incyte's raison d'être, as is the commitment to making a difference in patients' lives through scientific discovery.

Since the launch of Incyte Biosciences Iberia in 2016, we have invested more than €61 million in our commitment to healthcare.

Our team is comprised of more than 30 experts who are constantly working to bring innovative therapies available to patients in areas not covered in oncology and dermatology. The company's growing and diversified clinical portfolio, built on selection, fit and quality criteria, includes both small and large molecules.